TY - JOUR AU - Villanueva, A. PY - 2019 DA - 2019// TI - Hepatocellular carcinoma JO - N Engl J Med VL - 380 UR - https://doi.org/10.1056/NEJMra1713263 DO - 10.1056/NEJMra1713263 ID - Villanueva2019 ER - TY - JOUR AU - Yang, J. D. AU - Hainaut, P. AU - Gores, G. J. AU - Amadou, A. AU - Plymoth, A. AU - Roberts, L. R. PY - 2019 DA - 2019// TI - A global view of hepatocellular carcinoma: trends, risk, prevention and management JO - Nat Rev Gastroenterol Hepatol VL - 16 UR - https://doi.org/10.1038/s41575-019-0186-y DO - 10.1038/s41575-019-0186-y ID - Yang2019 ER - TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Massague, J. PY - 2008 DA - 2008// TI - TGFbeta in cancer JO - Cell VL - 134 UR - https://doi.org/10.1016/j.cell.2008.07.001 DO - 10.1016/j.cell.2008.07.001 ID - Massague2008 ER - TY - JOUR AU - Shi, Y. AU - Massague, J. PY - 2003 DA - 2003// TI - Mechanisms of TGF-beta signaling from cell membrane to the nucleus JO - Cell VL - 113 UR - https://doi.org/10.1016/S0092-8674(03)00432-X DO - 10.1016/S0092-8674(03)00432-X ID - Shi2003 ER - TY - JOUR AU - Massague, J. PY - 2008 DA - 2008// TI - A very private TGF-beta receptor embrace JO - Mol Cell VL - 29 UR - https://doi.org/10.1016/j.molcel.2008.01.006 DO - 10.1016/j.molcel.2008.01.006 ID - Massague2008 ER - TY - JOUR AU - Macias, M. J. AU - Martin-Malpartida, P. AU - Massague, J. PY - 2015 DA - 2015// TI - Structural determinants of Smad function in TGF-beta signaling JO - Trends Biochem Sci VL - 40 UR - https://doi.org/10.1016/j.tibs.2015.03.012 DO - 10.1016/j.tibs.2015.03.012 ID - Macias2015 ER - TY - JOUR AU - Petersen, M. AU - Pardali, E. AU - Horst, G. AU - Cheung, H. AU - Hoogen, C. AU - Pluijm, G. AU - Dijke, P. PY - 2010 DA - 2010// TI - Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2009.426 DO - 10.1038/onc.2009.426 ID - Petersen2010 ER - TY - JOUR AU - Ungefroren, H. AU - Groth, S. AU - Sebens, S. AU - Lehnert, H. AU - Gieseler, F. AU - Fandrich, F. PY - 2011 DA - 2011// TI - Differential roles of Smad2 and Smad3 in the regulation of TGF-beta1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1 JO - Mol Cancer VL - 10 UR - https://doi.org/10.1186/1476-4598-10-67 DO - 10.1186/1476-4598-10-67 ID - Ungefroren2011 ER - TY - JOUR AU - Brown, K. A. AU - Pietenpol, J. A. AU - Moses, H. L. PY - 2007 DA - 2007// TI - A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling JO - J Cell Biochem VL - 101 UR - https://doi.org/10.1002/jcb.21255 DO - 10.1002/jcb.21255 ID - Brown2007 ER - TY - JOUR AU - Kashiwagi, I. AU - Morita, R. AU - Schichita, T. AU - Komai, K. AU - Saeki, K. AU - Matsumoto, M. AU - Takeda, K. PY - 2015 DA - 2015// TI - Smad2 and Smad3 inversely regulate TGF-beta autoinduction in Clostridium butyricum-activated dendritic cells JO - Immunity VL - 43 UR - https://doi.org/10.1016/j.immuni.2015.06.010 DO - 10.1016/j.immuni.2015.06.010 ID - Kashiwagi2015 ER - TY - JOUR AU - Labbe, E. AU - Silvestri, C. AU - Hoodless, P. A. AU - Wrana, J. L. AU - Attisano, L. PY - 1998 DA - 1998// TI - Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2 JO - Mol Cell VL - 2 UR - https://doi.org/10.1016/S1097-2765(00)80119-7 DO - 10.1016/S1097-2765(00)80119-7 ID - Labbe1998 ER - TY - STD TI - Liao Z, Chen L, Zhang X, Zhang H, Tan X, Dong K, Lu X, et al. PTPRepsilon acts as a metastatic promoter in hepatocellular carcinoma by facilitating recruitment of SMAD3 to TGF-beta receptor 1. Hepatology. 2020. https://doi.org/10.1002/hep.31104. ID - ref13 ER - TY - JOUR AU - Lu, T. X. AU - Rothenberg, M. E. PY - 2018 DA - 2018// TI - MicroRNA JO - J Allergy Clin Immunol VL - 141 UR - https://doi.org/10.1016/j.jaci.2017.08.034 DO - 10.1016/j.jaci.2017.08.034 ID - Lu2018 ER - TY - JOUR AU - Chipman, L. B. AU - Pasquinelli, A. E. PY - 2019 DA - 2019// TI - miRNA targeting: growing beyond the seed JO - Trends Genet VL - 35 UR - https://doi.org/10.1016/j.tig.2018.12.005 DO - 10.1016/j.tig.2018.12.005 ID - Chipman2019 ER - TY - JOUR AU - Elkayam, E. AU - Kuhn, C. D. AU - Tocilj, A. AU - Haase, A. D. AU - Greene, E. M. AU - Hannon, G. J. AU - Joshua-Tor, L. PY - 2012 DA - 2012// TI - The structure of human argonaute-2 in complex with miR-20a JO - Cell VL - 150 UR - https://doi.org/10.1016/j.cell.2012.05.017 DO - 10.1016/j.cell.2012.05.017 ID - Elkayam2012 ER - TY - JOUR AU - Bartel, D. P. PY - 2018 DA - 2018// TI - Metazoan MicroRNAs JO - Cell VL - 173 UR - https://doi.org/10.1016/j.cell.2018.03.006 DO - 10.1016/j.cell.2018.03.006 ID - Bartel2018 ER - TY - JOUR AU - Yang, N. AU - Ekanem, N. R. AU - Sakyi, C. A. AU - Ray, S. D. PY - 2015 DA - 2015// TI - Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics JO - Adv Drug Deliv Rev VL - 81 UR - https://doi.org/10.1016/j.addr.2014.10.029 DO - 10.1016/j.addr.2014.10.029 ID - Yang2015 ER - TY - JOUR AU - Mott, J. L. PY - 2009 DA - 2009// TI - MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia JO - Hepatology VL - 50 UR - https://doi.org/10.1002/hep.23010 DO - 10.1002/hep.23010 ID - Mott2009 ER - TY - JOUR AU - Giordano, S. AU - Columbano, A. PY - 2013 DA - 2013// TI - MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? JO - Hepatology VL - 57 UR - https://doi.org/10.1002/hep.26095 DO - 10.1002/hep.26095 ID - Giordano2013 ER - TY - JOUR AU - Pan, L. AU - Huang, S. AU - He, R. AU - Rong, M. AU - Dang, Y. AU - Chen, G. PY - 2014 DA - 2014// TI - Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues JO - Eur J Med Res VL - 19 UR - https://doi.org/10.1186/s40001-014-0068-2 DO - 10.1186/s40001-014-0068-2 ID - Pan2014 ER - TY - JOUR AU - Xu, X. AU - Fan, Z. AU - Kang, L. AU - Han, J. AU - Jiang, C. AU - Zheng, X. AU - Zhu, Z. PY - 2013 DA - 2013// TI - Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis JO - J Clin Invest VL - 123 ID - Xu2013 ER - TY - JOUR AU - Gailhouste, L. AU - Gomez-Santos, L. AU - Hagiwara, K. AU - Hatada, I. AU - Kitagawa, N. AU - Kawaharada, K. AU - Thirion, M. PY - 2013 DA - 2013// TI - miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells JO - Hepatology VL - 58 UR - https://doi.org/10.1002/hep.26422 DO - 10.1002/hep.26422 ID - Gailhouste2013 ER - TY - JOUR AU - Ding, Z. Y. AU - Jin, G. N. AU - Wang, W. AU - Chen, W. X. AU - Wu, Y. H. AU - Ai, X. AU - Chen, L. PY - 2014 DA - 2014// TI - Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma JO - Hepatology VL - 60 UR - https://doi.org/10.1002/hep.27273 DO - 10.1002/hep.27273 ID - Ding2014 ER - TY - JOUR AU - Tang, Z. AU - Li, C. AU - Kang, B. AU - Gao, G. AU - Li, C. AU - Zhang, Z. PY - 2017 DA - 2017// TI - GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkx247 DO - 10.1093/nar/gkx247 ID - Tang2017 ER - TY - JOUR AU - Menyhart, O. AU - Nagy, A. AU - Gyorffy, B. PY - 2018 DA - 2018// TI - Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma JO - R Soc Open Sci VL - 5 UR - https://doi.org/10.1098/rsos.181006 DO - 10.1098/rsos.181006 ID - Menyhart2018 ER - TY - JOUR AU - Lewis, B. P. AU - Burge, C. B. AU - Bartel, D. P. PY - 2005 DA - 2005// TI - Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets JO - Cell VL - 120 UR - https://doi.org/10.1016/j.cell.2004.12.035 DO - 10.1016/j.cell.2004.12.035 ID - Lewis2005 ER - TY - JOUR AU - Chou, C. H. AU - Shrestha, S. AU - Yang, C. D. AU - Chang, N. W. AU - Lin, Y. L. AU - Liao, K. W. AU - Huang, W. C. PY - 2018 DA - 2018// TI - miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions JO - Nucleic Acids Res VL - 46 UR - https://doi.org/10.1093/nar/gkx1067 DO - 10.1093/nar/gkx1067 ID - Chou2018 ER - TY - JOUR AU - Jeggari, A. AU - Marks, D. S. AU - Larsson, E. PY - 2012 DA - 2012// TI - miRcode: a map of putative microRNA target sites in the long non-coding transcriptome JO - Bioinformatics VL - 28 UR - https://doi.org/10.1093/bioinformatics/bts344 DO - 10.1093/bioinformatics/bts344 ID - Jeggari2012 ER - TY - JOUR AU - Li, J. H. AU - Liu, S. AU - Zhou, H. AU - Qu, L. H. AU - Yang, J. H. PY - 2014 DA - 2014// TI - starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data JO - Nucleic Acids Res VL - 42 UR - https://doi.org/10.1093/nar/gkt1248 DO - 10.1093/nar/gkt1248 ID - Li2014 ER - TY - JOUR AU - Ying, Z. AU - Tian, H. AU - Li, Y. AU - Lian, R. AU - Li, W. AU - Wu, S. AU - Zhang, H. Z. PY - 2017 DA - 2017// TI - CCT6A suppresses SMAD2 and promotes prometastatic TGF-beta signaling JO - J Clin Invest VL - 127 UR - https://doi.org/10.1172/JCI90439 DO - 10.1172/JCI90439 ID - Ying2017 ER - TY - JOUR AU - Millet, C. AU - Zhang, Y. E. PY - 2007 DA - 2007// TI - Roles of Smad3 in TGF-beta signaling during carcinogenesis JO - Crit Rev Eukaryot Gene Expr VL - 17 UR - https://doi.org/10.1615/CritRevEukarGeneExpr.v17.i4.30 DO - 10.1615/CritRevEukarGeneExpr.v17.i4.30 ID - Millet2007 ER - TY - JOUR AU - Butz, H. AU - Racz, K. AU - Hunyady, L. AU - Patocs, A. PY - 2012 DA - 2012// TI - Crosstalk between TGF-beta signaling and the microRNA machinery JO - Trends Pharmacol Sci VL - 33 UR - https://doi.org/10.1016/j.tips.2012.04.003 DO - 10.1016/j.tips.2012.04.003 ID - Butz2012 ER - TY - JOUR AU - Jung, K. H. AU - Zhang, J. AU - Zhou, C. AU - Shen, H. AU - Gagea, M. AU - Rodriguez-Aguayo, C. AU - Lopez-Berestein, G. PY - 2016 DA - 2016// TI - Differentiation therapy for hepatocellular carcinoma: multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis JO - Hepatology VL - 63 UR - https://doi.org/10.1002/hep.28367 DO - 10.1002/hep.28367 ID - Jung2016 ER - TY - JOUR AU - Yan, H. AU - Dong, X. AU - Zhong, X. AU - Ye, J. AU - Zhou, Y. AU - Yang, X. AU - Shen, J. PY - 2014 DA - 2014// TI - Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma JO - Mol Carcinog VL - 53 UR - https://doi.org/10.1002/mc.22064 DO - 10.1002/mc.22064 ID - Yan2014 ER - TY - JOUR AU - Li, L. AU - Liu, Y. AU - Guo, Y. AU - Liu, B. AU - Zhao, Y. AU - Li, P. AU - Song, F. PY - 2015 DA - 2015// TI - Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma JO - Hepatology VL - 61 UR - https://doi.org/10.1002/hep.27543 DO - 10.1002/hep.27543 ID - Li2015 ER -